Nestle Acquires IM HealthScience, Expands Medical Food Lineup In Latest US Consumer Move
Nestle Health Science acquires IM HealthScience, marketer of medical foods IBgard and FDgard as well as prebiotic and sleep aid supplements. The deal is second recent US consumer health addition for the firm after it said 2020 would be “‘more vigorous” year for acquisitions despite the COVID-19 pandemic.
You may also be interested in...
Nestlé is in talks to acquire "all or part" of The Bountiful Company, owners of the Nature's Bounty brand and a leading player in the US supplements market. The Swiss firm revealed its interest in The Bountiful Company shortly after reporting double-digit growth at its Health Science business in Q1.
Nestlé Health Science saw sales rise double digits in 2020 thanks to higher demand for health and immunity products during the pandemic.
Nestle agrees to acquire Aimmune Therapeutics, maker of a drug indicated to reduce the severity of children’s allergic reactions to peanuts. It anticipates options to innovate in its consumer health children’s allergy business.